孕中期肾盂扩张:孕晚期持续与出生后转归及风险分层预测价值
单中心回顾性队列研究纳入孕中期诊断UTD并孕晚期随访的347例,孕晚期持续UTD占43%,出生后UTD占17%,仅2%需手术。2014 UTD共识分级A2-3对预测出生后UTD有一定判别能力(AUC 0.72)。
要点
- 孕中期UTD多数出生后不持续,持续者中仅少数需手术。
- 孕中期UTD分级A2-3及合并其他肾脏异常提示持续风险。
- 孕晚期AP-RPD增大和分级A2-3与出生后UTD相关。
核心结论
- 孕中期诊断的UTD多数出生后不持续,持续者中仅极少数需手术。
- 孕中期UTD后应进行孕晚期随访评估。
- 2014 UTD共识分级对预测出生后UTD具有中等准确度。
研究设计与样本
- 单中心回顾性队列研究,纳入2017年1月至2019年5月孕中期(<28周)诊断单侧或双侧UTD并孕晚期(≥28周)随访的单胎妊娠。
- 共分析347例有孕晚期随访,其中282例有出生后随访。
- 采用2014 UTD共识分类系统进行低风险(A1级)与增加风险(A2-3级)分层。
- 主要结局为孕晚期持续UTD和出生后6个月内UTD。
- 采用多变量分析和ROC曲线下面积(AUC)评估预测价值。
关键影像表现/征象
- 孕中期诊断UTD后,孕晚期持续UTD占43%(150/347,95%CI 38-49%)。
- 有出生后随访的282例中,出生后UTD占17%(49/282,95%CI 13-22%)。
- 孕晚期持续UTD者中出生后UTD占45%(46/102,95%CI 35-55%)。
- 出生后最常见诊断为暂时性UTD(76%),其次为重复集合系统(10%)。
诊断标准与关键数值
- 孕中期UTD分级A2-3预测孕晚期持续UTD的AUC为0.64(95%CI 0.58-0.70)。
- 孕中期UTD分级A2-3预测出生后UTD的AUC为0.72(95%CI 0.63-0.81)。
- 孕晚期UTD分级A2-3预测出生后UTD的AUC为0.66(95%CI 0.56-0.76)。
- 孕中期诊断UTD者中2%(7/347)需手术;出生后UTD者中14%(7/49)需手术。
临床应用与阅片要点
- 孕中期发现UTD应建议孕晚期(≥28周)超声随访。
- 报告UTD时按2014共识分级标注A1或A2-3,并描述有无其他肾脏异常。
- 孕晚期重点关注AP-RPD增大及分级A2-3,提示出生后UTD风险。
局限性
- 单中心回顾性研究,结果外推需谨慎。
- 部分病例缺乏出生后随访(仅282/347有随访)。
- 预测模型判别能力仅为中等(AUC 0.64-0.72)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To determine the frequency, associated characteristics and prognostic value of the current risk stratification system for prenatal urinary tract dilation (UTD) for predicting persistent UTD in the third trimester and subsequent postnatal UTD in the infant, following diagnosis in the second trimester.
METHODS: This was a single-institution retrospective cohort study of singleton pregnancies diagnosed with unilateral or bilateral UTD in the second trimester (before 28 weeks' gestation) with follow-up in the third trimester (at or after 28 weeks) between January 2017 and May 2019. In all cases, the prenatal diagnosis and stratification to low-risk (Grade A1) or increased-risk (Grade A2-3) UTD was made using the 2014 UTD consensus classification system. The primary outcomes included persistent prenatal UTD in the third trimester and postnatal UTD up to 6 months of age. We performed multivariable analysis to assess whether patient and second- and third-trimester sonographic characteristics (such as UTD laterality, other renal abnormality (calyceal dilation, abnormal parenchymal appearance, abnormal ureter or bladder) and anteroposterior renal pelvic diameter (AP-RPD)) were associated with the study outcomes. We assessed the predictive value of the current risk stratification system (Grade A1 vs Grade A2-3) in the second and third trimesters for persistent prenatal UTD and postnatal UTD using the area under the receiver-operating-characteristics curve (AUC).
RESULTS: Of 26 620 second-trimester ultrasound assessments in the study period, 347 patients were diagnosed with UTD in the second trimester and had third-trimester follow-up, of whom 150/347 (43% (95% CI, 38-49%)) had persistent UTD in the third trimester. Among the 282/347 (81%) patients with postnatal follow-up available, the frequency of postnatal UTD was 49/282 (17% (95% CI, 13-22%)), and among the subset with persistent UTD in the third trimester, the frequency of postnatal UTD was 46/102 (45% (95% CI, 35-55%)). The most frequent postnatal diagnosis was transient UTD (76%), followed by duplicated collecting system (10%). Of infants originally diagnosed with UTD in the second trimester, 2% (7/347) required surgery; stated differently, of the 49 infants with postnatal UTD, 14% (7/49) required surgery. At second-trimester diagnosis, sonographic predictors of both persistent prenatal UTD and postnatal UTD included the presence of other renal abnormality and UTD Grade A2-3. At third-trimester follow-up, predictors of postnatal UTD were larger mean AP-RPD and UTD Grade A2-3, while all cases had other renal abnormality. Second-trimester diagnosis of UTD Grade A2-3 had satisfactory discrimination for predicting persistent prenatal UTD (AUC, 0.64 (95% CI, 0.58-0.70)) and postnatal UTD (AUC, 0.72 (95% CI, 0.63-0.81)), as did third-trimester UTD Grade A2-3 for predicting postnatal UTD (AUC, 0.66 (95% CI, 0.56-0.76)).
CONCLUSIONS: The majority of cases of prenatal UTD did not result in postnatal UTD, and of those that did, very few required surgery. Follow-up third-trimester assessment after a second-trimester diagnosis of UTD is warranted. The current risk stratification system by UTD grade, based on the 2014 UTD consensus classification, can be used to predict postnatal UTD with fair accuracy. Further research is needed to determine whether the predictive performance of this system can be improved by incorporating additional risk factors. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Green CA, Adams JC, Goodnight WH, et al. Frequency and prediction of persistent urinary tract dilation in third trimester and postnatal urinary tract dilation in infants following diagnosis in second trimester. Ultrasound Obstet Gynecol. 2022. PMID: 34369632. doi:10.1002/uog.23758
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。